HR+/HER2- High-risk Breast Cancer Therapy
Improving Outcomes in Patients With High-risk Breast Cancer: Outcomes and Analysis From an Educational Program on HR+/HER2- Early and Metastatic Breast Cancer

Released: December 11, 2024

Expiration: December 10, 2025

Yara Abdou
Yara Abdou, MD
Stephanie L. Graff
Stephanie L. Graff, MD, FACP, FASCO
Tanya Gupta
Tanya Gupta, MD
Jane Meisel
Jane Meisel, MD
Michelle Melisko
Michelle Melisko, MD
Laura M. Spring
Laura M. Spring, MD

Activity

Progress
1
Course Completed